CINXE.COM
Imaging Starts Using Brand New Radiotracer from Nuclidium
<!doctype html><html lang="en"><head> <meta charset="utf-8"> <title>Imaging Starts Using Brand New Radiotracer from Nuclidium</title> <link rel="shortcut icon" href="https://oxfordglobal.com/hubfs/OXFORD_GLOBAL-LOGO_SYMBOL.jpg"> <meta name="description" content="The radiotracer is the first part of Nuclidium’s proposed ‘theranostic pipeline’ which aims to diagnose, stage, and then treat prostate cancer."> <meta name="viewport" content="width=device-width, initial-scale=1"> <meta property="og:description" content="The radiotracer is the first part of Nuclidium’s proposed ‘theranostic pipeline’ which aims to diagnose, stage, and then treat prostate cancer."> <meta property="og:title" content="Imaging Starts Using Brand New Radiotracer from Nuclidium"> <meta name="twitter:description" content="The radiotracer is the first part of Nuclidium’s proposed ‘theranostic pipeline’ which aims to diagnose, stage, and then treat prostate cancer."> <meta name="twitter:title" content="Imaging Starts Using Brand New Radiotracer from Nuclidium"> <style> a.cta_button{-moz-box-sizing:content-box !important;-webkit-box-sizing:content-box !important;box-sizing:content-box !important;vertical-align:middle}.hs-breadcrumb-menu{list-style-type:none;margin:0px 0px 0px 0px;padding:0px 0px 0px 0px}.hs-breadcrumb-menu-item{float:left;padding:10px 0px 10px 10px}.hs-breadcrumb-menu-divider:before{content:'›';padding-left:10px}.hs-featured-image-link{border:0}.hs-featured-image{float:right;margin:0 0 20px 20px;max-width:50%}@media (max-width: 568px){.hs-featured-image{float:none;margin:0;width:100%;max-width:100%}}.hs-screen-reader-text{clip:rect(1px, 1px, 1px, 1px);height:1px;overflow:hidden;position:absolute !important;width:1px} </style> <link rel="stylesheet" href="https://oxfordglobal.com/hs-fs/hub/8696823/hub_generated/template_assets/135726131582/1732113079147/git/og-stage/css/main.min.css"> <link rel="stylesheet" href="https://cdn.oxfordglobal.com/fontawesome/6.5.1/css/fontawesome.min.css"> <link rel="stylesheet" href="https://cdn.oxfordglobal.com/fontawesome/6.5.1/css/brands.min.css"> <link rel="stylesheet" href="https://cdn.oxfordglobal.com/fontawesome/6.5.1/css/solid.min.css"> <!-- Editor Styles --> <style id="hs_editor_style" type="text/css"> #hs_cos_wrapper_module_17019620504109 { display: block !important; margin-bottom: 0px !important } </style> <!-- Added by GoogleAnalytics4 integration --> <script> var _hsp = window._hsp = window._hsp || []; window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} var useGoogleConsentModeV2 = true; var waitForUpdateMillis = 1000; if (!window._hsGoogleConsentRunOnce) { window._hsGoogleConsentRunOnce = true; gtag('consent', 'default', { 'ad_storage': 'denied', 'analytics_storage': 'denied', 'ad_user_data': 'denied', 'ad_personalization': 'denied', 'wait_for_update': waitForUpdateMillis }); if (useGoogleConsentModeV2) { _hsp.push(['useGoogleConsentModeV2']) } else { _hsp.push(['addPrivacyConsentListener', function(consent){ var hasAnalyticsConsent = consent && (consent.allowed || (consent.categories && consent.categories.analytics)); var hasAdsConsent = consent && (consent.allowed || (consent.categories && consent.categories.advertisement)); gtag('consent', 'update', { 'ad_storage': hasAdsConsent ? 'granted' : 'denied', 'analytics_storage': hasAnalyticsConsent ? 'granted' : 'denied', 'ad_user_data': hasAdsConsent ? 'granted' : 'denied', 'ad_personalization': hasAdsConsent ? 'granted' : 'denied' }); }]); } } gtag('js', new Date()); gtag('set', 'developer_id.dZTQ1Zm', true); gtag('config', 'G-43QK8SYTST'); </script> <script async src="https://www.googletagmanager.com/gtag/js?id=G-43QK8SYTST"></script> <!-- /Added by GoogleAnalytics4 integration --> <link rel="canonical" href="https://oxfordglobal.com/precision-medicine/resources/imaging-starts-using-brand-new-radiotracer-from-nuclidium"> <meta property="og:image" content="https://oxfordglobal.com/hubfs/Website/Images/Resources/Biomarkers/Imaging%20Starts%20Using%20Brand%20New%20Radiotracer%20from%20Nuclidium.jpg"> <meta property="og:image:width" content="800"> <meta property="og:image:height" content="600"> <meta name="twitter:image" content="https://oxfordglobal.com/hubfs/Website/Images/Resources/Biomarkers/Imaging%20Starts%20Using%20Brand%20New%20Radiotracer%20from%20Nuclidium.jpg"> <meta property="og:url" content="https://oxfordglobal.com/precision-medicine/resources/imaging-starts-using-brand-new-radiotracer-from-nuclidium"> <meta name="twitter:card" content="summary"> <meta http-equiv="content-language" content="en"> <meta name="generator" content="HubSpot"></head> <body class="precision-medicine"> <div class="body-wrapper hs-content-id-177607188489 hs-site-page page "> <div data-global-resource-path="git/og-stage/templates/partials/header.html"> <header class="website-header "> <div class="navbar"> <div class="navbar-brands"> <a href="/precision-medicine" class="logo-link current-brand"> <img src="https://oxfordglobal.com/hubfs/Website/Logos/Brand%20Logos/Precision%20Medicine.svg" class="logo-image"> <i class="dropdown fa-solid fa-chevron-down"></i> </a> <div class="brands"> <div class="intro"> <h2> Explore our brands </h2> <div class="desc"> Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges. </div> </div> <div class="items"> <div class="item primary-brand"> <a href="/" class="logo-link"><img src="https://oxfordglobal.com/hubfs/logo.jpg" class="logo-image"></a> </div> <div class="item active-item"> <a href="/precision-medicine" class="logo-link"><img src="https://oxfordglobal.com/hubfs/Website/Logos/Brand%20Logos/Precision%20Medicine.svg" class="logo-image"></a> </div> <div class="item"> <a href="/discovery-development" class="logo-link"><img src="https://oxfordglobal.com/hubfs/Website/Logos/Brand%20Logos/Discovery%20%26%20Development.svg" class="logo-image"></a> </div> <div class="item"> <a href="/nextgen-biomed" class="logo-link"><img src="https://oxfordglobal.com/hubfs/Website/Logos/Brand%20Logos/NextGen%20Biomed.svg" class="logo-image"></a> </div> </div> </div> </div> <div class="flex flex-align-center navbar-nav"> <a href="#" class="navbar-nav-toggle"> <div class="toggle-icons"> <i class="fa-solid fa-bars toggle-open"></i> <i class="fa-solid fa-xmark toggle-close"></i> </div> </a> <ul class="navbar-nav-items"> <li class="navbar-nav-item"> <a href="#" class="navbar-nav-item-link">Events <i class="fa-solid fa-chevron-down"></i></a> <div class="navbar-subnav"> <div class="subnav-graphics"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Header%20Events.jpg" class="subnav-image"> </div> <div class="subnav-items"> <div class="subnav-item flex-3 divider g-20"> <div class="subnav-item-content bottom-mp-fix"> <h3> In-Person & Online Events </h3> <p>Pivotal moments where high-level industry experts and thought leaders come together for focused knowledge sharing and unparalleled networking opportunities.</p> </div> <div class="subnav-item"> <div class="event-pills"> <a href="/precision-medicine/events/spatial-biology-us-west-coast-2024" class="pill center"> <div class="b">Spatial Biology West Coast 2024</div> <div class="heading-smallcaps"> 04 - 05 Dec 2024 | San Diego, CA </div> </a> <a href="/precision-medicine/events/nextgen-omics-us-2025" class="pill center"> <div class="b">NextGen Omics & Spatial Biology US 2025</div> <div class="heading-smallcaps"> 27 - 28 Mar 2025 | Boston, MA </div> </a> <a href="/precision-medicine/events/biomarkers-precision-medicine-2025" class="pill center"> <div class="b">Biomarkers & Precision Medicine 2025</div> <div class="heading-smallcaps"> 30 Sep - 01 Oct 2025 | London, UK </div> </a> <a href="/precision-medicine/events/biomarkers-precision-medicine-us-2025" class="pill center"> <div class="b">Biomarkers & Precision Medicine US 2025</div> <div class="heading-smallcaps"> Oct 2025 | San Francisco, CA </div> </a> <a href="/precision-medicine/events/nextgen-multi-omics-2025" class="pill center"> <div class="b">NextGen Multi-Omics 2025</div> <div class="heading-smallcaps"> 13 - 14 Nov 2025 | London, UK </div> </a> </div> </div> </div> <div class="subnav-item flex-2"> <div class="subnav-item-content bottom-mp-fix"> <h3> Online Activities </h3> <p>Our Monthly Science Exchanges and Webinars keep you connected to the conversation.</p> </div> <div class="online-activities-list flex flex-column g-10"> <!-- Individual Online Activity --> <div class="online-activity"> <a href="/precision-medicine/online#Regulatory%20developments%20for%20biomarker%20research" class="cta" target="_blank"> <h3 class="other-resources">13/01/25 - Regulatory developments for biomarker research</h3> </a> </div> <div class="top-divider"></div> <!-- Individual Online Activity --> <div class="online-activity"> <a href="/precision-medicine/online#Sartorius%20Webinar" class="cta" target="_blank"> <h3 class="other-resources">10/04/25 - Sartorius Webinar</h3> </a> </div> </div> <div class="subnav-item-content-more"> <a href="/precision-medicine/online" class="subnav-item-content-more-link"><i class="fa-solid fa-circle-chevron-right"></i> All Online Activities</a> </div> </div> </div> </div> </li> <li class="navbar-nav-item"> <a href="#" class="navbar-nav-item-link">Community <i class="fa-solid fa-chevron-down"></i></a> <div class="navbar-subnav"> <div class="subnav-graphics"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Header%20Community.jpg" class="subnav-image"> </div> <div class="subnav-items"> <div class="subnav-item flex flex-1 divider"> <div class="subnav-item-content bottom-mp-fix"> <h3> About </h3> <p>We bring together pioneering minds from the biopharma and research communities, providing a platform for exchanging insights and accelerating the development of targeted therapies that transform patient outcomes</p> </div> <div class="subnav-item-content-more"> <a href="/precision-medicine/about" class="subnav-item-content-more-link"><i class="fa-solid fa-circle-chevron-right"></i> More Info</a> </div> </div> <div class="subnav-item flex flex-1 divider"> <div class="subnav-item-content bottom-mp-fix"> <h3> Community </h3> <p>Precision Medicine unites experts across the personalized healthcare landscape, including leaders in genomics, biomarker discovery, pathology, AI, targeted therapies, and data-driven diagnostics</p> </div> <div class="subnav-item-content-more"> <a href="/precision-medicine/community" class="subnav-item-content-more-link"><i class="fa-solid fa-circle-chevron-right"></i> More Info</a> </div> </div> <div class="subnav-item flex flex-1 "> <div class="subnav-item-content bottom-mp-fix"> <h3> Media Partners </h3> <p>We work with leading journal publications on reciprocal marketing arrangements.</p> </div> <div class="subnav-item-content-more"> <a href="/precision-medicine/media-partners" class="subnav-item-content-more-link"><i class="fa-solid fa-circle-chevron-right"></i> More Info</a> </div> </div> </div> </div> </li> <li class="navbar-nav-item"> <a href="#" class="navbar-nav-item-link">Services <i class="fa-solid fa-chevron-down"></i></a> <div class="navbar-subnav"> <div class="subnav-graphics"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Header%20Services.jpg" class="subnav-image"> </div> <div class="subnav-items"> <div class="subnav-item flex flex-1 divider"> <div class="subnav-item-content bottom-mp-fix"> <h3> In-Person Services </h3> <p>At Oxford Global, our events are designed to connect key life science figures and innovative solution providers, accelerating scientific advancement. Our goal is to create valuable connections and an impactful experience through innovative and collaborative formats.</p> </div> <div class="subnav-item-content-more"> <a href="/precision-medicine/in-person-services" class="subnav-item-content-more-link"><i class="fa-solid fa-circle-chevron-right"></i> More Info</a> </div> </div> <div class="subnav-item flex flex-1"> <div class="subnav-item-content bottom-mp-fix"> <h3> Digital Marketing Services </h3> <p>Oxford Global’s products offer a powerful channel to associate your brand with the latest advancements within the industry whilst educating and influencing the industry throughout their buying process.</p> </div> <div class="subnav-item-content-more"> <a href="/precision-medicine/digital-marketing-services" class="subnav-item-content-more-link"><i class="fa-solid fa-circle-chevron-right"></i> More Info</a> </div> </div> </div> </div> </li> <li class="navbar-nav-item"> <a href="#" class="navbar-nav-item-link">Resources <i class="fa-solid fa-chevron-down"></i></a> <div class="navbar-subnav"> <div class="subnav-graphics"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Header%20Resources.jpg" class="subnav-image"> </div> <div class="subnav-items"> <div class="subnav-item flex-2 divider"> <div class="subnav-item-content bottom-mp-fix"> <h3> Browse All Resources </h3> <p>The latest in multi-omics, biomarker & imaging research, spanning from discovery & development to diagnostics and precision medicine.</p> </div> <div class="subnav-item-content-more"> <a href="/precision-medicine/resources" class="subnav-item-content-more-link"><i class="fa-solid fa-circle-chevron-right"></i> All Precision Medicine Resources</a> </div> </div> <div class="subnav-item flex-4 divider"> <div class="subnav-item-content bottom-mp-fix"> <h3> Latest Resources </h3> <div class="resources"> <div class="resource"> <div class="resource-cover"> <a href="/precision-medicine/resources/alzheimers-society-continue-5m-blood-biomarker-challenge-for-dementia-blood-tests-on-nhs" class="resource-cover-link"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Resources/Precision%20Medicine/Alzheimers%20Society%20Continue%20%C2%A35m%20Blood%20Biomarker%20Challenge%20for%20Dementia%20Blood%20Tests%20on%20NHS.jpg" class="resource-cover-image"> </a> </div> <div class="resource-content"> <h3 class="resource-heading"> <a href="/precision-medicine/resources/alzheimers-society-continue-5m-blood-biomarker-challenge-for-dementia-blood-tests-on-nhs">Alzheimer's Society Continue £5m Blood Biomarker Challenge for Dementia Blood Tests on NHS</a> </h3> <div class="resource-abstract"> <span class="resource-date">14/11/24 - </span> The Blood Biomarker Challenge hopes to ‘revolutionize dementia diagnosis in the UK’ through a collaborative pilot of blood tests in the NHS. </div> </div> </div> <div class="top-divider"></div> <div class="resource"> <div class="other-resources"><a href="/precision-medicine/resources/keck-team-integrate-multi-omics-with-environmental-data-for-precision-environmental-health">13/11/24 - Keck Team Integrate Multi-Omics with Environmental Data for Precision Environmental Health</a></div> </div> <div class="top-divider"></div> <div class="resource"> <div class="other-resources"><a href="/precision-medicine/resources/syn-saa-biomarker-highly-correlated-with-dementia-with-lewy-bodies">31/10/24 - αSyn-SAA Biomarker Highly Correlated with Dementia with Lewy Bodies</a></div> </div> </div> </div> </div> <div class="subnav-item flex-3"> <div class="subnav-item-content bottom-mp-fix"> <h3> Featured Resource </h3> <div class="resources flex flex-column g-5"> <a href="https://oxfordglobal.com/precision-medicine/resources/sponsored/webinar/sapient/a-new-golden-age-for-target-identification"> <div class="sponsor-resource flex-column"> <div class="resource-cover img-fluid"> <div class="sponsor-resource-cover-link"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Resources/Omics/Sapient%20Webinar%20Website%20Featured%20Image.jpg" class="sponsor-resource-cover-image"> </div> </div> <div class="resource-content p-15"> <h3 class="resource-heading"> A New Golden Age for Target Identification: Accessing the Novel Druggable Space with Discovery Proteomics </h3> <div class="resource-abstract"> On-demand webinar presented by Mo Jain, MD, PhD, Founder and CEO, Sapient and Jonathan Usuka, PhD, MBA Chief Business Officer, Sapient </div> </div> </div> </a> </div> </div> </div> </div> </div> </li> <li class="navbar-nav-item show-sm hide-md hide-lg hide-xl"> <a href="javascript:postMessage({type:'HS_DISPLAY_CALL_TO_ACTION',id:130207947529});" class="navbar-nav-item-link">Contact</a> </li> <li class="navbar-nav-item show-sm hide-md hide-lg hide-xl"> <a href="#" class="navbar-nav-item-link">Our Brands <i class="fa-solid fa-chevron-down"></i></a> <div class="navbar-subnav"> <div class="subnav-items"> <h2> Explore our brands </h2> <div class="desc"> Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges. </div> <div class="subnav-item"> <div class="subnav-item-content"> <a href="/">Oxford Global</a> </div> </div> <div class="subnav-item"> <div class="subnav-item-content"> <a href="/precision-medicine">Precision Medicine</a> </div> </div> <div class="subnav-item"> <div class="subnav-item-content"> <a href="/discovery-development">Discovery & Development</a> </div> </div> <div class="subnav-item"> <div class="subnav-item-content"> <a href="/nextgen-biomed">NextGen Biomed</a> </div> </div> </div> </div> </li> </ul> </div> <div class="flex flex-align-center hide-sm show-md show-lg show-xl"> <a href="javascript:postMessage({type:'HS_DISPLAY_CALL_TO_ACTION',id:130207947529});" class="navbar-button">Contact</a> </div> </div> </header></div> <main id="main-content"> <div class="resource-single"> <div class="header bg-primary-light"> <div class="container-wrapper"> <div class="wide-container header-container"> <div class="header-content flex-1"> <div class="heading-smallcaps"> Diagnostic Development | Industry Spotlights & Insight Articles </div> <h1 class="heading"> Imaging Starts Using Brand New Radiotracer from Nuclidium </h1> <div class="byline"> Edited by Tom Cohen | 21 October 2024 </div> <div class="abstract"> The radiotracer is the first part of Nuclidium’s proposed ‘theranostic pipeline’ which aims to diagnose, stage, and then treat prostate cancer. </div> </div> <div class="header-graphic flex-1"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Resources/Biomarkers/Imaging%20Starts%20Using%20Brand%20New%20Radiotracer%20from%20Nuclidium.jpg" class="header-graphic-image"> </div> </div> </div> </div> <div class="container-wrapper"> <div class="wide-container"> <div class="content"> <div class="content-body text-gap"> <p>Clinical imaging has begun in a phase I clinical trial to assess a new radiotracer from <a href="https://nuclidium.com/" rel="noopener" target="_blank">Swiss ‘theranostic’ biotech Nuclidium</a>. <sup>61</sup>Cu-NuriPro (<sup>61</sup>Cu-NODAGA-PSMA I&T) is a disease staging imaging agent for prostate cancer.</p> <p>This imaging agent is the diagnostic part of Nuclidium’s wider NuriPro program which uses copper radionuclides to tackle prostate cancer. NuriPro binds to Prostate Specific Membrane Antigen (PSMA), an established <a href="https://oxfordglobal.com/precision-medicine/events/biomarkers-us-2024" rel="noopener" target="_blank">biomarker for the diagnosis, staging, and treatment of prostate cancer.</a></p> <p><strong>Read more:</strong></p> <ul> <li><a href="https://oxfordglobal.com/precision-medicine/resources/study-analyses-predictive-biomarkers-for-covid-19-icu-patient-mortality" rel="noopener" target="_blank">Study Analyses Predictive Biomarkers for COVID-19 ICU Patient Mortality</a></li> <li><a href="https://oxfordglobal.com/precision-medicine/resources/group-identify-prognostic-biomarker-for-sclc-and-treatment-using-chemotherapy" rel="noopener" target="_blank">Group Identify Prognostic Biomarker for SCLC and Treatment Using Chemotherapy</a></li> <li><a href="https://oxfordglobal.com/precision-medicine/resources/proteomic-analysis-of-serum-extracellular-vesicles-reveals-potential-biomarkers-for-neuroblastoma" rel="noopener" target="_blank">Proteomic Analysis of Serum Extracellular Vesicles Reveals Potential Biomarkers for Neuroblastoma</a></li> </ul> <p>Clinical testing of the NuriPro program is currently being conducted at Hoag Memorial Hospital Presbytarian in Newport Beach, CA. The investigator initiated, non-randomised phase I trial will evaluate the safety and efficacy of <sup>61</sup>Cu-NuriPro as a diagnostic imaging tool for prostate cancer.</p> <p>Gary Ulaner, Director of Molecular Imaging and Therapy at Hoag Memorial Hospital Presbyterian and Principal Investigator of the trial said: “Prostate cancer remains the most frequently diagnosed cancer and the second most common cause of cancer death in American men. Rapid and precise diagnosis is essential for effective treatment.”</p> <p>The trial will compare the candidate to an already FDA-approved, Fluorine-18 based, PSMA-targeting radiotracer. Nuclidium says that its radiotracer candidate can offer benefits when compared to other currently available solutions.</p> <p>“Copper-based candidates have shown greater imaging capacity with less toxicity in pre-clinical studies. Copper’s unique properties allow us to establish the first true theranostic pipeline that can achieve more accurate staging of the individual patient and more precise treatment of their disease,” said Leila Jaafar, CEO and Co-Founder of Nuclidium.</p> <p>She continued: “Our NuriPro diagnostic’s imaging profile can overcome both detection and production challenges for physicians and patients living with prostate cancer and we look forward to further exploring its potential.”</p> <p>Furthermore, Nuclidium’s candidate offers a 3.3 hour half-life, compared to the current average of 1 to 2 hours from existing products. This allows <sup>61</sup>Cu-NuriPro to have further distribution range after production.</p> <p>The company boasts ease of manufacture for their product at room temperature, which enables on-demand preparation and a simplified and easy-to-apply workflow with reduced need for laboratory equipment. Furthermore, Nuclidium also <a href="https://www.businesswire.com/news/home/20241021269969/en/NUCLIDIUM-Announces-First-Patient-Imaged-in-Phase-1-Study-Evaluating-61Cu-based-Radiotracer-in-Patients-with-PSMA-positive-Prostate-Cancer/?feedref=JjAwJuNHiystnCoBq_hl-bV7DTIYheT0D-1vT4_bKFzt_EW40VMdK6eG-WLfRGUE1fJraLPL1g6AeUGJlCTYs7Oafol48Kkc8KJgZoTHgMu0w8LYSbRdYOj2VdwnuKwa" rel="noopener" target="_blank">said a press release</a>: “It [<sup>61</sup>Cu-NuriPro] further enables delayed imaging, allowing for the detection of even the smallest metastases.”</p> <p>Regarding the latest results from the ongoing trial, Ulaner commented: “The first patient has not experienced any adverse events so far and the scan with <sup>61</sup>Cu-NuriPro showed more osseous lesions than <sup>18</sup>F-piflufolastat, at 1 hour post-injection. Also, the PET scans with <sup>61</sup>Cu-NuriPro identified more osseous lesions at 2 and 4 hours compared to 1 hour post-injection. These preliminary clinical findings are in accordance with the preclinical results and underline the potential, favourable imaging performance of <sup>61</sup>Cu-NuriPro.”</p> <p>Along with the diagnostic portion of the program, Nuclidium are also developing a therapeutic radionuclide <sup>67</sup>Cu-NuriPro (<sup>67</sup>Cu-NODAGA-PSMA I&T) currently in its preclinical stages, which aims to treat patients with prostate cancer. The company aims to begin a phase I clinical trial of <sup>67</sup>Cu-NuriPro in 2025.</p> Upon successful completion of the trial, Nuclidium wants to advance their NuriPro program into a Phase I/II theranostic clinical trial. This would evaluate both the 61Cu-based imaging radiotracer as well as the 67Cu-based therapeutic candidate. <div class="content-body-footer"> </div> </div> <div class="content-sidebar"> <div class="related-articles"> <h3 class="center">Related Resources</h3> <div class="article"> <a href="/precision-medicine/resources/immunoassay-solutions-for-biomarker-analysis"> <div class="cover-graphic"> <img src="https://oxfordglobal.com/hubfs/Website/Documents/Whitepaper%20Upload%2022.10.24/AB0285_Immunoassay_Solutions_Ab_Pairs_UPDATE_DIGITAL%20(1).jpg" class="cover-graphic-image"> </div> </a><div class="content"><a href="/precision-medicine/resources/immunoassay-solutions-for-biomarker-analysis"> <h4> Immunoassay Solutions for Biomarker Analysis </h4> <div class="abstract"> </div> <div class="read-more"> <a href="/precision-medicine/resources/immunoassay-solutions-for-biomarker-analysis" class="read-more-link">Read More</a> </div></a> </div> </div> <div class="article"> <a href="/precision-medicine/resources/diagnexia-analytix-pathology-services"> <div class="cover-graphic"> <img src="https://oxfordglobal.com/hubfs/Website/Documents/Whitepaper%20Upload%2022.10.24/Diagnexia%20Analytix%20Brochure.jpg" class="cover-graphic-image"> </div> </a><div class="content"><a href="/precision-medicine/resources/diagnexia-analytix-pathology-services"> <h4> Diagnexia Analytix Pathology Services </h4> <div class="abstract"> </div> <div class="read-more"> <a href="/precision-medicine/resources/diagnexia-analytix-pathology-services" class="read-more-link">Read More</a> </div></a> </div> </div> </div> </div> </div> </div> </div> </div> <div class="newsletter-cta"> <h2 class="heading">Subscribe to our newsletter</h2> <div class="message"> Sign up for our monthly Newsletter to keep up with all things Precision Medicine </div> <div class="button-wrapper"> <a href="#" class="button hs-cta-trigger-button hs-cta-trigger-button-177053686110">Newsletter Sign-Up</a> </div> </div> </main> <div data-global-resource-path="git/og-stage/templates/partials/footer.html"><footer class="website-footer flex flex-column g-20"> <div class="footer-columns"> <div class="footer-column"> <a href="https://oxfordglobal.com" class="site-logo-link"> <img src="https://oxfordglobal.com/wp-content/uploads/2023/03/Oxford-Global-Logo-Stacked-Websize.png" class="site-logo"> </a> </div> <div class="footer-column"> <h3>Brands</h3> <ul> <li> <a href="/precision-medicine/">Precision Medicine</a> </li> <li> <a href="/discovery-development/">Discovery & Development</a> </li> <li> <a href="/nextgen-biomed/">NextGen Biomed</a> </li> </ul> </div> <div class="footer-column"> <h3>Services</h3> <ul> <li> <a href="https://oxfordglobal.com/in-person-services/"> In-Person Services </a> </li> <li> <a href="https://oxfordglobal.com/digital-marketing-services/"> Digital Marketing Services </a> </li> </ul> <h3>Upcoming Events</h3> <ul> <li> <a href="https://oxfordglobal.com/calendar/"> Event Calendar </a> </li> </ul> </div> <div class="footer-column"> <h3>Company</h3> <ul> <li class="elementor-icon-list-item"> <a href="https://oxfordglobal.com/about-us/"> About </a> </li> <li class="elementor-icon-list-item"> <a href="https://oxfordglobal.com/vacancies/"> Vacancies </a> </li> <li class="elementor-icon-list-item"> <a href="https://oxfordglobal.com/csr-policy/"> CSR Policy </a> </li> <li class="elementor-icon-list-item"> <a href="javascript:postMessage({type:'HS_DISPLAY_CALL_TO_ACTION',id:130207947529});"> Contact </a> </li> </ul> </div> <div class="footer-column"> <p> <a href="tel:+441865248455">+44 1865 248 455</a><br> <a href="mailto:help@oxfordglobal.com">help@oxfordglobal.com</a> </p> <p> <strong>Our UK Address:</strong><br> Godstow Court<br> Minns Business Park<br> Botley<br> Oxford, OX2 0JB </p> <p> <strong>Our US Address:</strong><br> 100 Cambridge Street<br> 14th Floor<br> Boston<br> MA 02114 </p> </div> </div> <div class="footer-bottom grid g-20"> <div class="span8 span12-sm span12-md flex flex-column g-10"> <div class="copyright"> © Oxford Global Marketing Ltd. All rights reserved. </div> <ul class="legal-links flex flex-row g-30 flex-column-sm g-sm-10"> <li><a href="https://oxfordglobal.com/legal/">Terms & Conditions</a></li> <li><a href="https://oxfordglobal.com/legal/privacy-policy/">Privacy Policy</a></li> <li><a href="https://oxfordglobal.com/legal/website-terms/">Cookies</a></li> <li><a href="https://www.wishagency.co.uk/" target="_BLANK">Digital Agency Wish</a></li> </ul> </div> <div class="span4 span12-sm span12-md flex-align-end"> <ul class="social-links flex flex-row flex-justify-end flex-justify-center-sm flex-justify-center-md g-30"> <li><a href="https://www.facebook.com/OGConferences/" target="_BLANK"><i class="fa-brands fa-square-facebook"></i></a></li> <li><a href="https://www.linkedin.com/company/oxford-global/" target="_BLANK"><i class="fa-brands fa-linkedin"></i></a></li> <li><a href="https://twitter.com/OGConferences" target="_BLANK"><i class="fa-brands fa-square-x-twitter"></i></a></li> </ul> </div> </div> </footer></div> </div> <script src="/hs/hsstatic/jquery-libs/static-1.1/jquery/jquery-1.7.1.js"></script> <script>hsjQuery = window['jQuery'];</script> <!-- HubSpot performance collection script --> <script defer src="/hs/hsstatic/content-cwv-embed/static-1.1293/embed.js"></script> <script src="https://oxfordglobal.com/hs-fs/hub/8696823/hub_generated/template_assets/182600797781/1731148644227/git/og-stage/js/inlineSVG.min.js"></script> <script src="https://oxfordglobal.com/hs-fs/hub/8696823/hub_generated/template_assets/135724366742/1725380923802/git/og-stage/js/main.min.js"></script> <script> function getVideoId(url) { var regExp = /^.*(youtu.be\/|v\/|u\/\w\/|embed\/|watch\?v=|\&v=)([^#\&\?]*).*/; var match = url.match(regExp); if (match && match[2].length == 11) { return match[2]; } else { return false; } } function getVideoEmbed(id) { return '<iframe src="https://www.youtube.com/embed/' + id + '" title="YouTube video player" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" allowfullscreen style="aspect-ratio: 16 / 9; width: 100%;"></iframe>'; } jQuery("div.content-body .wp-block-embed__wrapper:contains('youtu')").each(function() { var yt_url = $(this).html().trim(); var yt_id = getVideoId(yt_url); var yt_embed = getVideoEmbed(yt_id); $(this).html(yt_embed); }); </script> <!-- Start of HubSpot Analytics Code --> <script type="text/javascript"> var _hsq = _hsq || []; _hsq.push(["setContentType", "standard-page"]); _hsq.push(["setCanonicalUrl", "https:\/\/oxfordglobal.com\/precision-medicine\/resources\/imaging-starts-using-brand-new-radiotracer-from-nuclidium"]); _hsq.push(["setPageId", "hubdb-177607188489-94056879-181754169888"]); _hsq.push(["setContentMetadata", { "contentPageId": "hubdb-177607188489-94056879-181754169888", "legacyPageId": "hubdb-177607188489-94056879-181754169888", "contentFolderId": null, "contentGroupId": null, "abTestId": null, "languageVariantId": 177607188489, "languageCode": "en", }]); </script> <script type="text/javascript" id="hs-script-loader" async defer src="/hs/scriptloader/8696823.js"></script> <!-- End of HubSpot Analytics Code --> <script type="text/javascript"> var hsVars = { render_id: "aa2687f9-c239-42ce-969d-023cf8f5d808", ticks: 1732335442266, page_id: 177607188489, dynamic_page_id: "hubdb-177607188489-94056879-181754169888", content_group_id: 0, portal_id: 8696823, app_hs_base_url: "https://app.hubspot.com", cp_hs_base_url: "https://cp.hubspot.com", language: "en", analytics_page_type: "standard-page", scp_content_type: "", analytics_page_id: "hubdb-177607188489-94056879-181754169888", category_id: 1, folder_id: 0, is_hubspot_user: false } </script> <script defer src="/hs/hsstatic/HubspotToolsMenu/static-1.354/js/index.js"></script> </body></html>